This is a working overview of RP-HPLC, written for readers who want more than a one-paragraph summary but less than a textbook.
This page was last updated on 2025-09-03 and is reviewed periodically as new material appears.
Interest in AOD-9604 arose from attempts to separate metabolic effects from growth effects attributed to hGH. Early work explored whether the fragment could influence lipolysis or fat oxidation without promoting growth. Those questions remain partly unresolved because human data are limited and results have varied across studies. The peptide is not a hormone replacement for hGH and is not equivalent to hGH in clinical use. Its research history includes both laboratory studies and commercial marketing claims that are not the same as regulatory approval.
AOD-9604 is a synthetic peptide whose structure corresponds to a C-terminal segment of human growth hormone. It is often described as hGH fragment 176-191, a 16-amino-acid sequence. The peptide was designed to isolate a region of hGH associated with fat metabolism while avoiding the full hormone's growth-promoting actions. Laboratory and commercial materials typically present it as a lyophilized powder for research use. Its identity is defined by amino acid sequence, not by a single brand.
Laboratory studies have reported that AOD9604 can increase lipolysis and reduce lipid accumulation in fat cells. The precise molecular target remains uncertain, and the compound does not appear to activate the growth hormone receptor in the same way as full-length hGH. Proposed mechanisms include effects on beta-adrenergic signaling and enzymes involved in fatty acid synthesis, but these pathways are not firmly established. Because most evidence comes from cell and animal models, whether the same effects occur in humans is an open question.
Clinical development of AOD9604 included trials in people with obesity, but the results did not lead to approval as a prescription medicine in major markets. Interest later shifted to research settings and to unapproved products marketed for body composition. Regulatory agencies have questioned whether the peptide qualifies as a dietary ingredient, and some have issued warnings about its presence in supplements. Long-term human safety data are limited, and questions about efficacy, dosing, and target populations remain unresolved.
AOD9604 is a synthetic peptide modeled on the C-terminal region of human growth hormone. It corresponds to a short sequence near the end of the 191-amino-acid hormone, often described as residues 176–191 or a related fragment. Researchers designed it to separate metabolic effects from the growth-promoting actions of full-length growth hormone. Early work in the 1990s explored it as a candidate for weight and lipid disorders. It is not a naturally circulating hormone fragment produced in large amounts.
| Property | Value | Notes |
|---|---|---|
| Molecular class | Synthetic peptide | Based on the C-terminal region of human growth hormone. |
| Amino acid length | 16 residues | Often described as hGH fragment 176-191. |
| Appearance | Lyophilized powder | Typically white to off-white; exact appearance depends on grade. |
| Solubility | Soluble in water | Aqueous solubility depends on pH, ionic strength, and preparation. |
| Typical storage | -20 °C or lower | Lyophilized peptide is usually kept cold and dry; solutions may require freezing. |
Commercial AOD-9604 may vary in purity, counterion content, and residual moisture. Certificates of analysis often report HPLC purity, mass confirmation, and appearance, but testing methods differ between suppliers. Independent verification is sometimes used because labeled content may not match actual peptide amount. Stability under different pH and temperature conditions is not fully standardized across studies. Researchers generally treat lyophilized material as the reference form for weighing and reconstitution. Moisture content can affect accurate mass measurement.
AOD-9604 is typically supplied as a lyophilized white to off-white powder. In this form, it is relatively stable when kept cool, dry, and protected from light. Common storage recommendations place it at −20 °C or below for long-term retention. Reconstituted solutions are less stable and are often kept at 2–8 °C for short periods. Freeze-thaw cycles should be minimized because they can promote aggregation or loss of peptide content. Vials are usually sealed under inert gas to reduce oxidation.
Regulatory bodies have taken different approaches to AOD-9604. It is not approved as a prescription medicine by major agencies such as the U.S. Food and Drug Administration or the European Medicines Agency. In sport, the World Anti-Doping Agency prohibits peptide hormones, growth factors, and related substances, and AOD-9604 has been treated as a prohibited substance. These regulatory decisions reflect concerns about safety, efficacy, and potential misuse rather than proof of benefit.
Research on AOD-9604 also examines how the peptide is measured in biological samples. Analytical methods may include liquid chromatography coupled with mass spectrometry, immunoassays, or both. Detection can be challenging because the peptide is small and may be present at low concentrations. Published methods vary in sensitivity and specificity, so comparative interpretation requires attention to validation details. The presence of related hGH fragments can complicate identification in some matrices.
Quality varies among research-grade suppliers, so certificates of analysis and independent testing are important for verification. A typical certificate reports purity by HPLC, identity by mass spectrometry, appearance, and sometimes residual solvents or water content. AOD9604 is often sold as a research chemical not intended for human consumption, and labels can be inaccurate. Common misconceptions include treating the peptide as a form of growth hormone, assuming supplement status, or expecting approved-drug quality from unregulated products.
AOD9604 is commonly supplied as a white to off-white lyophilized powder. The powder is typically stored at -20 °C or below, protected from light and moisture, because peptides can degrade through oxidation, hydrolysis, or aggregation. If it is reconstituted for laboratory use, an appropriate aqueous buffer or solvent is chosen, and the solution is kept cold and handled to avoid repeated freeze-thaw cycles. These practices support stability but do not imply suitability for human use.
=== Store giveaway === In October 2009, TCBY launched the "This Could Be Yours: The Great TCBY Store Giveaway," a contest that rewarded one person with their own TCBY store. To enter, contestants submitted a video, no longer than two minutes, explaining why they should be the recipient of their very own TCBY, why their town is the perfect location, and what they have to offer the brand. Submissions were judged on creativity, a sense of business acumen and originality. Originally, videos were accepted until November 30, 2009, but the deadline was extended until March 31, 2010. On May 26, 2010, it was announced that the winners of the contest were Jared and Sarah Greer of Fayetteville, Arkansas. The Greers opened their store in April 2011 in Rogers, Arkansas with TCBY's new self-serve prototype and store design.
Results for other ASEAN states are mixed: Malaysia dropped from 12 to 14, Indonesia from 37 to 42, with the Philippines moving up from 42 to 41. IMD World Competitiveness Yearbook 2014: Thailand ranked 29 of 60 nations.
A hypobaric chamber, or altitude chamber, is a chamber used during aerospace or high terrestrial altitude research or training to simulate the effects of high altitude on the human body, especially hypoxia (low oxygen) and hypobaria (low ambient air pressure). Some chambers also control for temperature and relative humidity.
== Former chains == A&W Restaurants - defunct in 2004 Burger Machine – now a food stall chain Cindy's - established Tarlac 1972, fastfood chain defunct by 2000s Go Nuts Donuts - defunct in 2020 IHOP - introduced 2014, local branches closed in 2022 Manong Pepe's - Jollibee Food Corporation venture into low cost carinderia style fast food. First store opened in 2007 and all stores closed down in 2011 Teddy's Bigger Burgers
Sources: en.wikipedia.org
=== Human use === Cobweb paintings, which began during the 16th century in a remote valley of the Austrian Tyrolean Alps, were created on fabrics consisting of layered and wound cobwebs, stretched over cardboard to make a mat, and strengthened by brushing with milk diluted in water. A small brush was then used to apply watercolor to the cobwebs, or custom tools to create engravings. Fewer than a hundred cobweb paintings survive today, most of which are held in private collections. In traditional European medicine, cobwebs were used on wounds and cuts to reduce bleeding and aid healing. This use was recorded in ancient Greece and Rome, and was mentioned in Shakespeare's A Midsummer Night's Dream. Spider webs have been shown to significantly reduce wound healing times. They are rich in vitamin K, which is essential in blood clotting, and their large surface area is also thought to help coagulation. During the 1st century BC, the Roman army used spider webs as field dressings, which also served as a fungicide. The effects of some drugs can be measured by examining their effects on a spider's web-building. In northeastern Nigeria, cow horn resonators in traditional xylophones often have holes covered with spider webs to create a buzzing sound. Spider web strands have been used for crosshairs or reticles in telescopes. Development of technologies to mass-produce spider silk has led to the manufacturing of prototype military protection, wound dressings and other medical devices, and consumer goods. Spider webs can be used as a single step catalyst to make nanoparticles.
== Regulation == Some of the strategies for regulating retinal dehydrogenases are only now becoming more clear after in vivo regulation remained mysterious for some time, though much of the current research on regulation has focused on the modulation of gene expression rather than direct protein regulation. Dendritic cells in the gut help in modulating immune tolerance through the activity of retinal dehydrogenase; expression in these cells may be driven by a TNF receptor, 4-1-BB. It was also shown that the expression of a certain retinal dehydrogenase found in humans, retinal short-chain dehydrogenase/reductase (retSDR1), is increased by tumor-suppressor proteins p53 and p63, suggesting that retSDR1 may have tumor-preventing activities. Expression of retinal dehydrogenase types 1 and 2 genes is enhanced by the addition of cholesterol or cholesterol derivatives. Disulfiram is a drug used to artificially regulate aldehyde dehydrogenase activity in patients with alcoholism by inhibiting the activity of aldehyde dehydrogenases, though it is not specific to retinal dehydrogenase. Other exogenous molecules have also been found to inhibit retinal dehydrogenase activity including nitrofen, 4-biphenyl carboxylic acid, bisdiamine, and SB-210661.
ELPs modified with certain functional groups have the capacity to be conjugated with drugs, including chemotherapeutic agents. Together, the ELP-drug complex can be taken up by tumor cells to a greater extent, promoting the cytotoxic activity of the drug. The reason that the complexes preferentially target the tumor cells is that these cells tend to be associated with more permeable blood vessels and also possess a weaker lymphatic presence. This essentially means that the drugs can cross over from the vessels to the tumor cells more frequently and can remain in the vessels for a longer period of time, without being filtered out. The phase transition associated with ELPs can also be used to promote tumor cell uptake of the drug. By locally heating tumor cell regions, the ELP-drug complex will aggregate into spherical clumps. If this ELP-drug complex is engineered to expose functional domains in the spherical clump shape that are recognized by tumor cell surfaces, then this cell surface interaction would promote uptake of the drug as the tumor cell would mistake the ELP-drug complex as being a harmless substance.
A schematic diagram of instrumentation which can be used for electron ionization is shown to the right. The ion source block is made out of metal. As the electron source, the cathode, which can be a thin filament of tungsten or rhenium wire, is inserted through a slit to the source block. Then it is heated up to an incandescent temperature to emit electrons. A potential of 70 V is applied between the cathode and source block to accelerate them to 70 eV kinetic energy to produce positive ions. The potential of the anode (electron trap) is slightly positive and it is placed on the outside of the ionization chamber, directly opposite to the cathode. The unused electrons are collected by this electron trap. The sample is introduced through the sample hole. To increase the ionization process, a weak magnetic field is applied parallel to the direction of the electrons' travel. Because of this, electrons travel in a narrow helical path, which increases their path length. The positive ions that are generated are accelerated by the repeller electrode into the accelerating region through the slit in the source block. By applying a potential to the ion source and maintaining the exit slit at ground potential, ions enter the mass analyzer with a fixed kinetic energy. To avoid the condensation of the sample, the source block is heated to approximately 300 °C.
=== Threats to other countries === Trump set his sights on a number of countries in the following days. Trump signaled an eagerness to apply pressure on Colombia and said when asked that a similar operation there "sounds good to me". Trump threatened Colombia's president Gustavo Petro, saying he has "cocaine mills and cocaine factories" and "likes making cocaine and selling it to the United States" but would not be doing it much longer. Trump had recently sanctioned the Colombian leader for his alleged reluctance to combat drug trafficking in the country. Petro promised to take up arms if he had to, and Colombia's Ministry of Foreign Affairs issued a statement opposing "an undue interference" in domestic politics. Days later Trump and Petro agreed in a phone call to work together on combating drug trafficking and domestic insurgency, with Petro demanding that Trump "strike hard" against the ELN in both Venezuela and Colombia; Petro said fighting the ELN "in the rear" was just as critical as attacking it inside Colombia. Trump threatened Mexico and Cuba, saying the two nations needed to do more to earn US favor, but said the latter might "fall" without US interference; he also expressed hope that Mexico would act on its own. In an appearance on Hannity Trump said that "We are going to start now hitting land with regard to the cartels. The cartels are running Mexico". Newsweek noted that Trump had said land strikes were imminent before, but also that he had been doing the groundwork by designating cartels Foreign Terrorist Organizations.
Sources: en.wikipedia.org
The mole (symbol mol) is a unit of measurement, the base unit in the International System of Units (SI) for amount of substance. One mole is an aggregate of exactly 6.02214076×1023 elementary entities which can be atoms, molecules, ions, ion pairs, or other particles. This number of entities equals 602,214,076,000,000,000,000,000, approximately 602 sextillion or 602 billion multiplied by one trillion. The number of particles in a mole is the Avogadro number (symbol N0) and the numerical value of the Avogadro constant (symbol NA) has units of mol−1. The relationship between the mole, Avogadro number, and Avogadro constant can be expressed in the following equation:
== Pharmacodynamics == CPA has antiandrogenic activity, progestogenic activity, weak partial glucocorticoid activity, weak steroidogenesis inhibitor activity, and agonist activity at the pregnane X receptor. It has no estrogenic or antimineralocorticoid activity. In terms of potency, CPA is described as a highly potent progestogen, a moderately potent antiandrogen, and a weak glucocorticoid.
The drills continued the following day and were closely monitored by the militaries of both Australia and New Zealand. The New Zealand Government allocates NZ$200 million of funding for the City Rail Link to removing level crossings in order to ease traffic congestion in Auckland. Andrew Bayly resigns as Minister of Commerce and Consumer Affairs after he "placed a hand" on a staff member's upper arm on 18 February, in what Bayly acknowledges as "overbearing" behavior. 22 February: Police investigate five suspected overnight church arson attempts in Masterton. Chinese warships conduct a second live firing exercise in the Tasman Sea. Prime Minister Luxon confirms that Australian and New Zealand naval forces including HMNZS Te Kaha are monitoring the Chinese vessels. 23 February: LGBT supporters gather in Auckland's Albert Park to protest against Destiny Church's disruption of Pride events on 15 February. The New Zealand Police confirm they are investigating graffiti at the former location of Auckland's Kadimah School, which was discovered on 6 February. 24 February – The Police confirmed they have seized 76 gang patches and filed 337 charges for alleged insignia breaches under the Gangs Act 2024. 25 February: Immigration Minister Erica Stanford announces the Government will ease residency rules to recruit more primary school teachers from overseas. Executive director Helen Potiki and legal counsels Nick Whittington and Kristy McDonald KC resign from the second phase of the Royal Commission of Inquiry into COVID-19 Lessons Learned.
== The Chemical Basis of Growth and Senescence (1923) == In between 1916 and 1920 Robertson published a series of 16 papers in the Journal of Biological Chemistry under the title Experimental Studies on Growth. The papers became the foundation of his (1923) textbook, The Chemical Basis of Growth and Senescence (BR.39): a work that examined the "self-accelerated" natural processes of growth and aging in plants, animals, and humans (as they were understood at that time). Using mathematical principles, Robertson employed an S-Curve (a.k.a. 'sigmoid curve') (p.5) to demonstrate both the "autokinetic phase" of a "self-accelerated" growth process, "during which the rate of growth is continuously increasing" (p.4), and its "autostatic phase", "during which the rate of growth is decreasing" (p.4). Drawing an analogy to the autocatalyzed chemical reactions of Wilhelm Ostwald (father of his Berkeley colleague Wolfgang Ostwald), Robertson referred to these "self-accelerated" processes as being "autocatalyzed" (p.6). As Lee and Hanson observed (in 1947), "[Robertson's] theory of autocatalytic control over growth ... has been variously rejected, acknowledged and accepted by investigators" (RL.1, p.53).
Sources: en.wikipedia.org
It is a synthetic peptide based on a C-terminal fragment of human growth hormone. It is commonly referred to as hGH fragment 176-191 and is studied for metabolic effects rather than growth effects.
No. It represents only a short portion of the hGH sequence and lacks the full hormone's structure. As a result, its biological activity and regulatory status differ from those of prescription hGH.
The exact peptide is not typically described as a circulating hormone; it is a synthetic construct based on a natural sequence. Fragments of hGH can exist in laboratory or metabolic contexts, but AOD-9604 itself is manufactured for research.
AOD9604 is a synthetic peptide based on a C-terminal segment of human growth hormone. It is manufactured by chemical peptide synthesis rather than extracted from human tissue. The sequence is often described as hGH fragment 176–191 or a close variant.